In the United States, rates were higher in Black men than White men for all BC subtypes, while among women, rates in Black people were 21% lower for HR+/HER2−, comparable for HR+/HER2+, 29% higher for HR−/HER2+ and 93% higher for TNBC [109]. This evidence concerns the gene ERBB2 and breast cancer.